R

Rewind Therapeutics

19 employees

Rewind Therapeutics is a developer of novel therapeutics intended to facilitate the treatment for neurological diseases.

Basic info

Industry

biotechnology research

Sectors

myelin
Biotechnology
multiple sclerosis
therapy
Therapeutics
biotech

Date founded

2017

Funding rounds raised

Total raised

$18M

from 5 investors over 5 rounds

R

Rewind Therapeutics raised undisclosed on January 25, 2023

Investors: KU Leuven Innovation & Entrepreneurship, Sunstone Life Science Ventures and M Ventures

R

Rewind Therapeutics raised $18M on January 4, 2018

Investors: KU Leuven Innovation & Entrepreneurship and M Ventures

FAQ